ERBB2 and neoplasm: While NGS tends to be more cost intensive than ddPCR, we believe that this approach offers a more encompassing view of the tumor’s molecular profile, allowing the detection of alterations at very low VAFs, as well as co-mutations in other clinically relevant genes, such as PIK3CA, BRCA1/2, AKT1, and ERBB2.